Ligand Pharmaceuticals (LGND) Current Deferred Revenue (2010 - 2025)
Ligand Pharmaceuticals' Current Deferred Revenue was $111,000 in Q2 2025, down 90.7% from $1.2 million a year earlier but up 9.9% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Current Deferred Revenue (2010 - 2025) Analysis & Trends
At the end of FY2024, Current Deferred Revenue at Ligand Pharmaceuticals came in at $1.28 million, up 4.6% from FY2023.
- Current Deferred Revenue shows a five-year compound annual growth rate of -9.8% (FY2019 to FY2024).
- In earlier years, Current Deferred Revenue was $1.22 million in FY2023 (+244.2%), $355,000 in FY2022 (-45.7%), $654,000 in FY2021 (-97.8%) and $29.44 million in FY2020.
- Quarterly Current Deferred Revenue has moved between $101,000 (Q1 2025) and $29.44 million (Q4 2020) over five years.
- Compared with a year earlier, Current Deferred Revenue was higher in three of the last five quarters, with growth averaging 88.8%.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q1 2021 (growth of 476.6%); the worst was Q4 2021 (a decline of 97.8%).
- Per Business Quant data, LGND's Current Deferred Revenue in the three quarters before Q2 2025 was $101,000 (Q1 2025), $1.28 million (Q4 2024) and $1.15 million (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ligand Pharmaceuticals | 6.22 Bn | 2.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 111,000.00 |
| Mar 31, 2025 | 101,000.00 |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Mar 31, 2023 | 257,000.00 |
| Dec 31, 2022 | 355,000.00 |
| Sep 30, 2022 | 9.55 Mn |
| Jun 30, 2022 | 10.58 Mn |
| Mar 31, 2022 | 10.50 Mn |
| Dec 31, 2021 | 654,000.00 |
| Sep 30, 2021 | 12.01 Mn |
| Jun 30, 2021 | 17.15 Mn |
| Mar 31, 2021 | 25.11 Mn |
| Dec 31, 2020 | 29.44 Mn |
| Sep 30, 2020 | 5.40 Mn |
| Jun 30, 2020 | 8.92 Mn |
| Mar 31, 2020 | 4.35 Mn |
API Access
Ligand Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();